Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
DC passes pharma rep licensing bill
Soon, pharma sales folk could be ticketed for repping without a license. The District of Columbia's governing council voted to require sales reps to obtain licenses, becoming the only jurisdiction in the country to do so.
The vote was close--seven to six. And the final measure lacked a provision that would have prohibited data-mining of doctors' prescribing habits. Nevertheless, the primary provision stands. Once licensed, reps could be suspended for fraudulent behavior.
- read the article in the Washington Post
- here's more from the Washington Business Journal
Related Articles:
DC to vote on rep-licensing bill. Report
Dr. Drug Rep tells all. Report
Top Lilly exec plays secret sales agent. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


